Silver Book Fact

Satisfaction with HVD Treatment

Among treated heart valve disease (HVD), 96% express “full satisfaction” and 78% are “very satisfied” with their treatment.

Report of Findings from Opinion Research among Heart Valve Disease Patients. http://www.agingresearch.org/backend/app/webroot/files/Publication/370/Research%20Opinion%20Survey%20among%20Heart%20Valve%20Patients_Final.pdf. Published 2016. Accessed October 16, 2017

Reference

Title
Report of Findings from Opinion Research among Heart Valve Disease Patients
Publication Date
Published 2016
Authors
Belden Russanello Strategists
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Life expectancy and quality of life gains from AVR
    A study of 4,617 patients who underwent aortic valve replacement (AVR) over a period of 20 years found significant gains in life expectancy and quality of life — 43,166 net life-years…  
  • TAVR Procedures 2011 – 2015
    From approval in 2011 through 2015, >54,000 transcatheter aortic valve replacements (TAVRs) were performed in 418 centers in 48 states.  
  • TAVR v. SAVR in Intermediate-Risk SAS Patients
    At 1-year, severe aortic stenosis (SAS) patients with intermediate surgical mortality risk who underwent transcatheter aortic valve replacement (TAVR), had all-cause mortality rates of 7.4% (compared to 13% for surgical…  
  • TAVR Success in sSAS Patients
    A study of severe symptomatic aortic stenosis (sSAS) patients who received transcatheter aortic valve replacement (TAVR) found 30-day mortality of 2.2% for those who were high risk of surgical mortality/inoperable,…  
  • Cost-effectiveness of SAVR
    The cost-effectiveness ratio for surgical aortic valve replacement (SAVR), compared to no surgery, was estimated at $13,528 per quality-adjusted life year (QALY) (~$17,225 in 2017 dollars).